|
Tevogen Bio Holdings Inc (NASDAQ: TVGN) |
|
Tevogen Bio Holdings Inc
TVGN's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Tevogen Bio Holdings Inc 's sales fell
in the fourth quarter of 2024 from the same quarter a year ago.
Biotechnology & Pharmaceuticals industry recorded
deterioration of revenues by -2.05 %
Tevogen Bio Holdings Inc net loss increased from $-1 millions, to $-9 millions in fourth quarter of 2024,
• More on TVGN's Growth
|
|
Tevogen Bio Holdings Inc realized a net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 763.76 in trailing twelve-month period. Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.17.
• More on TVGN's Valuation
|
|
|
|
|
Tevogen Bio Holdings Inc realized net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 763.76 in trailing twelve-month period. Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.17.
• More on TVGN's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com